Journal of Young Pharmacists logo
Submit
Journal of Young PharmacistsACADEMIC PUBLISHING
Article

Multisystem Inflammatory Syndrome in Adults (MIS-A): A Case Report

1, 2★★ Corresponding author

  1. 1Department of General Medicine, Maharishi Markandeshwar Institute of Medical Science and Research, Ambala, Haryana, INDIA.
  2. 2University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, INDIA.

CORRESPONDENCE

Navneet Kaur

University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, INDIA.

kaurnavneet7329@gmail.com

Received: 29-07-2022; Revised: 12-08-2022; Accepted: 01-09-2022.

Volume 14, Issue 4 · pp. 449-450 · 2022 · DOI: 10.5530/jyp.2022.14.92

ABSTRACT

The Severe Acute Respiratory Syndrome (SARS-CoV-2) pandemic has reverberated into calamitous illness globally, even though children have been comparatively reprieved. Coronavirus-associated multisystem inflammatory syndrome (MIS) has been outlined in children (MIS-C) and hardly ever in adults (MIS-A) in as much as April and June 2020, sequentially. Whilst the rudimentary immunopathology is not well demarcated, adaptive immunity is contemplated to be blameworthy. We report a case of Multisystem inflammatory syndrome in children lie illness – MIS-A who presented with fever, pain abdomen, weakness and low oxygen saturation in an emergency. Truenat for SARS-CoV-2 came out negative but covid serology IGG came positive. The clinical presentation of the patient was in maintained with the clinically accepted definition of MIS-A.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Batra, N., & Kaur, N. (2022). Multisystem Inflammatory Syndrome in Adults (MIS-A): A Case Report. Journal of Young Pharmacists, 14(4), 449-450. https://doi.org/10.5530/jyp.2022.14.92

    Copyright and licence

    © 2022 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0